fluoxetine

In this episode, Dr. Zach April returns to review the SSRI's. These are some of the best treatment options for mood. We talk about what to expect in general with these medications and review some of the individual medicines including sertraline (Zoloft), fluoxetine (Prozac) and escitalopram (Lexapro) to name a few. 

A disclaimer, we're providing general guidance but everyone is different and you should always discuss with your health care professional management of any disease and therapy before trying anything you discover from a source on the internet (including this podcast)

This month - with about 1 in 10 people in the UK on antidepressant drugs, we're asking what's it like to come off of these medications? How well is this change managed? And how can this be improved? Like this podcast? Please help us by supporting the Naked Scientists

On MIA Radio this week, MIA's Zenobia Morrill interviews Dr. Vance Trudeau, a professor at the University of Ottawa in Canada. Dr. Trudeau describes a recent study he conducted, alongside a team of researchers, led by Dr. Marilyn Vera-Chang, that has implications for understanding of the long-term impact of antidepressant drug exposure (see MIA report).

The study, titled Transgenerational hypocortisolism and behavioral disruption are induced by the antidepressant fluoxetine in male zebrafish Danio rerio linked antidepressant exposure to decreased coping behaviors in zebrafish that lasted several generations. Dr. Trudeau is the research chair in neuroendocrinology at the University of Ottawa, where he studies how the brain regulates hormonal activity in fish and frogs. Such analyses offer important insights into the effects of environmental exposures on human health because these hormonal systems are shared across species.

© Mad in America 2019

This audio program summarizes how to teach supportive psychotherapy; continuation treatment with fluoxetine in treatment-responsive children and adolescents; a group treatment program for borderline personality disorder; regional expression of GABA-related genetic transcripts in the neocortex of schizophrenia patients; the relationship between cannabis use and loss of brain volume in schizophrenia; and the association of nicotine dependence with low dopamine D2 receptor availability in the striatum. Articles can be viewed online at www.ajp.psychiatryonline.org.